Hint mode is switched on Switch off

Clovis Oncology, ordinary share
0A7C, US1894641000

Add a stock to WL
Choose all Reset all
Clovis Oncology, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
Clovis Oncology, Inc. (Clovis) is a Development-stage Company. The Company is a Biopharmaceutical Company. The Company focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets. The Company also ...
Clovis Oncology, Inc. (Clovis) is a Development-stage Company. The Company is a Biopharmaceutical Company. The Company focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets. The Company also focuses on the treatment of specific subsets of cancer populations.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Clovis Oncology, Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CLVS
  • Placement
    16.11.2011
  • Lock up period
    180
  • Number of papers
    10,000,000
  • Volume of raised funds
    130 mln USD
  • Final placement price
    13 USD
  • Price change since placement date
    -100%
  • By capitalization
    281.63 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CLVS
  • Placement
    04.01.2017
  • Lock up period
    180
  • Number of papers
    5,000,000
  • Volume of raised funds
    205 mln USD
  • Placement share
    11.47%
  • Final placement price
    41 USD
  • Price change since placement date
    -100%
  • By capitalization
    1,786.89 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CLVS
  • Placement
    19.05.2020
  • Lock up period
    180
  • Number of papers
    11,090,000
  • Volume of raised funds
    89.27 mln USD
  • Placement share
    12.61%
  • Final placement price
    8.05 USD
  • Price change since placement date
    -100%
  • By capitalization
    707.74 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2022
I q eng
II q eng
III q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Indicators

News

10/07/2023 Clovis Oncology: Bankruptcy Or Receivership, Material Modifications To The Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors And Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Other Events, Financial Statements And Exhibits
30/06/2023 Clovis Oncology: Material Modifications To The Rights Of Security Holders, Regulation Fd Disclosure, Financial Statements And Exhibits
26/05/2023 Clovis Oncology: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
02/05/2023 Clovis Oncology: Regulation Fd Disclosure, Financial Statements And Exhibits
01/05/2023 Clovis Oncology: Completion Of Acquisition Or Disposition Of Assets
All organization news

Holders

Industry Leaders

Registration is required to get access.